INTRODUCTION
Inflammatory bowel disease (IBD) is a chronic inflam matory disorder with an increasing prevalence. It in cludes ulcerative colitis (UC) and Crohn's disease (CD).
Epidemiological studies have demonstrated a rising incidence of IBD in Chinese children. In 2001, it was reported that the incidence of pediatric IBD was 0.5/ million, while in 2011, the incidence increased to 6.1/ million [1] . Pediatric IBD has severe phenotypes, extensive intestinal involvement, rapid progression, and has several side issues, including growth failure, poor bone density, and delayed puberty. Thus, it is important to investigate the pathogenesis of pediatric IBD.
The etiology of IBD remains unknown, and multiple factors may be involved in its development, including infection, the immune system, genetics, and the envi ronment [2, 3] . High expression of tumor necrosis factor (TNF)α has been found in most pediatric IBD patients. TNFα plays an important role in microRNA expression.
MicroRNAs are families of small (approximately 20 nucleotides long), noncoding RNAs. They play a defini tive regulatory role in innate and adaptive immune pro cesses [4, 5] . microRNA expression has been shown to be altered in adult patients suffering from CD and UC. Wu et al [6] reported that the levels of 11 microRNAs were altered in UC patient colons and that microRNA (miR)192 negatively regulated TNFα in IBD patients. Iborra et al [7] showed that the levels of several microRNAs were increased in CD and UC patients. Takagi et al [8] reported that miR21 and miR15 were upregulated in UC pa tients. However, most studies have been conducted in adults, and there are only a limited number of studies examining microRNAs in children with IBD. Béres et al [9] showed that the level of miR155 was increased in pediatric IBD patients and that its levels increased after TNFα stimulation in vitro. Cell division cycle (Cdc)42 is a small GTPase of the Rho family that acts as a molecular switch by cycling be tween an active GTPbound form and an inactive GDP bound form. It controls various cellular functions, inclu ding adhesion, migration, transcription and growth [10, 11] . It has a special role in hematopoietic stem cell regu lation [12, 13] and is critical for intestinal stem cell division, survival and differentiation in mice [14] . It has recently been reported that Cdc42 is critical for intestinal epithelial stem cell differentiation and formation of a functional intestinal barrier [15, 16] . The epithelial barrier plays a critical role in maintaining intestinal homeostasis and is formed by multiple inter cellular junctions, including the apical junctional complex (AJC), tight junction (TJ) and adherens junction (AJ), which are the major protein complexes of the AJC [17] . TJs are composed of occludin, claudins, junctional adhesion molecules (JAMs), and the zona occludens (ZO) family of proteins. AJs are formed by Ecadherin [18] . A number of studies in IBD patients have demonstrated that intestinal barrier function is disrupted in both active and quiescent disease states [16, 19, 20] . Several studies have shown that microRNAs partici pate in the development of IBD, and miR15 has an al tered expression level in IBD patients, but the underlying mechanisms are not fully elucidated. Recently, microRNA Cdc42 signaling has been studied by some researchers; they have shown that miR137 negatively regulates H2O2induced cardiomyocyte apoptosis through Cdc42 [21] . MiR17 is involved in Japanese flounder development by targeting Cdc42 mRNA [22] , and miR106b negatively regulates Cdc42 in human colorectal cancer cells [23] . We used Target Scan and found the putative seed region of miR15a in the wildtype 3'UTR of Cdc42 ( Figure 1A ). As Cdc42 is critical for intestinal barrier function, we hypothesized that miR15a regulates Cdc42 to disrupt the intestinal barrier in IBD development.
MATERIALS AND METHODS

Patients
Chinese Han pediatric IBD patients were included in this study. The diagnosis of CD and UC was based on clinical symptoms, endoscopic findings, and histopathology according to the Porto criteria [24] . Disease activity score was calculated by Pediatric Crohn's Disease Activity Index (PCDAI) and Pediatric Ulcerative Colitis Activity Index (PUCAI). Age and sexmatched Chinese Han juvenile polyp patients were enrolled as a control group. Colonoscopy was used for diagnosis, and the ileocecal mucosa showed normal macroscopic appearance with normal histology in the biopsy specimens.
Ileocecal tissues of all patients were collected by endoscopy, frozen in liquid nitrogen, and stored at 80 ℃ until further analysis. All tissues had been histologically confirmed.
Cell culture
293T cells were a generous gift from Dr. HuaQing Zhong (Institute of Pediatrics, Children's Hospital of Fudan University), and Caco2 cells were purchased from Genechem (Shanghai, China). They were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 1% nonessential amino acids, 1% penicillinstreptomycin antibiotic solution (Gibco) and 1 mmol/L Lglutamine at 37 ℃ in 5% CO2. The cells were passaged at 80% confluence with a 0.25% trypsinEDTA solution for 35 min.
Cell transfection
Plasmid transfection. The following plasmids were used: hsamir15a and its negative control, Cdc42 [NM 0017913UTR (miR15a5p)] and its negative control, Cdc42 [NM0017913UTR (miR15a5p)]mut. All of the plasmids were purchased from Genechem. Transfection was performed using Xtremegene HP (Roche). At 48 h after transfection, cells were harvested for further experiments.
Lentiviral transfection. The following lentiviruses were used: miR15a mimic and its negative control (UbiMCSSV40EGFPIRESpuromycin LVcon220), miR115a inhibitor and its negative control (hU6MCS ubiquitinEGFPIRESpuromycin LVcon137), and Cdc42 and its negative control (UbiEGFPMCSIRESpuromycin LVcon129). All of the lentiviruses were purchased from Genechem. At 12 h after transfection, cells were cultured in regular media, and after 48 h, cells were harvested for further experiments. 
TNF-α -stimulated cells
Quantitative reverse transcription polymerase chain reaction
Total RNA was extracted using TRIzol reagent (Thermo Scientific). For analysis of microRNA expression, the MiScript Ⅱ RT Kit (Qiagen) was used to convert RNA into cDNA. Quantitative reverse transcription polymerase chain reaction (qRTPCR) was performed using the SYBR Premix Ex Taq Ⅱ kit (Takara). The PCR conditions were set as follows: 95 ℃ for 30 s, followed by 40 cycles of 95 ℃ for 5 s and 60 ℃ for 30 s. U6 was used as a reference gene for microRNA15a, GAPDH was used as a reference gene for all other genes. Relative expression was analyzed by the 2 −ΔΔCt method. The primers used in this study are listed in Table 1 .
Dual-luciferase reporter assay
To determine whether Cdc42 was a direct target of miR 15a, a dual luciferase assay was performed using 293T cells. Mutant Cdc42 3′UTR reporters were created by get gene of miR15a ( Figure 1A ). We then constructed firefly luciferase reporter vectors containing either wild type Cdc42 3'UTR (Cdc42WT) or mutated Cdc42 3'UTR with a modified miR15a binding site (Cdc42MUT). We transfected 293T cells with either Cdc42WT or Cdc42 MUT, along with plasmid containing miR15a mimics (miR15a) or its negative control plasmid (miRNC). At 48 h after transfection, we used a dualluciferase reporter assay to examine the relative luciferase activities. The relative luciferase activities were decreased in cells cotransfected with Cdc42WT and miR15a mimics com pared to cells cotransfected with Cdc42MUT and miR 15a mimics ( Figure 1B , P < 0.05), confirming that Cdc42 was a direct target of miR15a.
TNF−α induces miR-15a upregulation and Cdc42 downregulation in Caco-2 cells
We cultured Caco2 cells and passaged 1 × 10 5 cells in 35mm dishes. After 24 h, we cultured cells with medium containing 35 ng/mL TNFα (TNFα group) or regular medium (control group) for 60 h and then harvested. qRTPCR demonstrated that miR15a levels increased upon TNFα treatment compared to the control group ( Figure 2A ), while Cdc42 levels decreased in the TNFα group compared to the control group ( Figure 2B ). These results suggest that TNFα induced miR15a upregulation and Cdc42 downregulation, and high TNFα expression has been found in most pediatric patients [25] .
MiR-15a negatively regulates Cdc42 expression in Caco-2 cells
We transfected Caco2 cells with miR15a mimic lenti virus and its negative control (miR15aNC) or miR15a inhibitor lentivirus and its negative control (LVNC) and found no difference in miR15a and Cdc42 expression between the two negative control groups. In the miR 15a mimic group, miR15a was overexpressed compared to the negative control group ( Figure 3A ). In the miR 15a inhibitor group, miR15a expression was decreased compared to the negative control group ( Figure 3A ). Cdc42 was downregulated in the miR15a mimic group and upregulated in the miR15a inhibitor group ( plates. After 24 h, hsamir15a mimic plasmid and its negative control (miRNC) were cotransfected with either Cdc42WT or Cdc42MUT luciferase reporter vector; 48 h after transfection, a Dual Luciferase Reporter Assay System (Promega, Madison, WI, United States) was used to examine the relative luciferase activities. Relative luciferase activities were normalized to the value with Cdc42MUT and miRNC cotransfection.
Immunofluorescence
Caco2 cells (5 × 10 4 ) were passaged in 35mm confocal dishes, washed in phosphate buffer solution (PBS), and fixed with 4% paraformaldehyde for 20 min. Cells were permeabilized with PBST for 10 min, blocked with 4% bovine serum albumin at room temperature for 30 min, incubated with primary antibody solution at 4 ℃ overnight, and secondary antibody solution at room temperature for 1 h, and DAPI solution for 5 min. Immunofluorescence images were captured using a Leica confocal microscope and analyzed by Photoshop version 7.0.
Antibodies were used as follows: antiZO1 at 1:400 (Cell Signaling Technology, #13663), antiEcadherin at 1:200 (Cell Signaling Technology, #3195), and secondary antibody was Dnk pAb to Rb IgG (Alexa Fluor 647, Abcam).
Statistical analysis
All experiments were performed in triplicate. All data are expressed as the mean ± standard deviation (SD). The statistical analysis of differences was performed using t test of variance and Pearson's r test of correlation using GraphPad Prism version 6.0. P < 0.05 was considered statistically significant.
RESULTS
Cdc42 is a novel target of miR-15a
We searched the online microRNAs target database Target Scan and found that Cdc42 was a candidate tar
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). These results demonstrate that miR15a negatively regulates Cdc42 in Caco2 cells.
MiR-15a overexpression downregulates epithelial junctions, while overexpressed Cdc42 rescues low epithelial junction protein expression induced by miR15a upregulation or high TNF-α expression
We found that in the TNFα group, the epithelial junction proteins Ecadherin and ZO1 were decreased compared to the control (WT) group ( Figure 4AD ). In the miR15a mimic group, Ecadherin and ZO1 were also decreased compared with the WT group ( Figure 4AD ). We found no difference in Ecadherin and ZO1 expression between the WT and miR15aNC groups.
We transfected Caco2 cells with miR15a inhibitor lentivirus or its negative control (LVNC). After passage, we added 35 ng/mL TNFα to stimulate the cells for 60 h (miR15a inhibitor + TNFα or LVNC + TNFα). Ecadherin and ZO1 expression did not change in the miR15a inhibitor + TNFα cells compared to the WT group ( Figure 4AD ). Ecadherin and ZO1 expression was similar in the LVNC + TNFα group to the WT + TNFα group.
We also transfected Caco2 cells with Cdc42 lentivirus (LvCdc42) or its negative control (LvCdc42NC). Cdc42 was overexpressed in the LvCdc42 group compared to the LvCdc42NC group, but there were no differences between the WT and LvCdc42NC groups. Expression of Ecadherin and ZO1 was not different in the LvCdc42 NC group compared to the WT cells or the miR15aNC group.
We then used 35 ng/mL TNFα to stimulate LvCdc42 (LvCdc42 + TNFα) and LvCdc42NC cells (LvCdc42 NC + TNFα) for 60 h and found that Ecadherin and ZO1 expression decreased in the LvCdc42NC + TNFα cells compared to the WT cells ( Figure 4AD ), while it increased in the LvCdc42 + TNFα cells compared to the miR15a mimic or LvCdc42NC + TNFα cells ( Figure  4AD ).
Taken together, these results demonstrate that over expressed TNFα can disrupt the intestinal epithelial barrier. miR15a overexpression can damage the in testinal epithelia similarly to TNFα overexpression. Increased Cdc42 expression can reverse the damage caused by miR15a overexpression. Figure 4 MicroRNA-15a negatively regulates epithelial junctions through cell division cycle 42 in Caco-2 cells. Caco-2 cells were stimulated by Tumor necrosis factor-α (TNF-α) (35 ng/mL) [wild type (WT) + TNF-α group] or medium with no TNF-α (WT). Caco-2 cells were transfected with miR-15a mimic lentivirus or its negative controls (miR-NC group). Caco-2 cells were transfected with microRNA-15a (miR-15a) inhibitor lentivirus, and after passage, were stimulated by TNF-α (35 ng/mL) (miR-15a inhibitor + TNF-α). Caco-2 cells were transfected with Cdc42 lentivirus (Lv-Cdc42) or its negative control (Lv-Cdc42-NC), and after passage, stimulated by TNF-α (35 ng/mL) (Lv-Cdc42 +TNF-α or Lv-Cdc42nc + TNF-α group). A: Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to evaluate the relative mRNA expression of E-cadherin (E-Cad) in every group; B: Expression of epithelial marker E-cad was examined by immunofluorescence in every group. Cells were stained with E-cad antibodies and counter stained with DAPI; C: qRT-PCR was used to evaluate the relative mRNA expression of ZO-1 in every group; D: Expression of epithelial marker ZO-1 was examined by immunofluorescence in every group. Cells were stained with E-cad antibodies and counterstained with DAPI ( a P < 0.05, b P < 0.01 vs WT, c P < 0.05, d P < 0.01 vs miR-15a mimic, e P < 0.05 vs Lv-Cdc42-NC +TNF-α) (magnification 40 ×, bar = 25 μm). 
MiR-15a negatively regulates Cdc42 in pediatric IBD patients and is correlated with PCDAI
We investigated the expression of miR15a and Cdc42 in 33 pediatric IBD patients (26 CD and seven UC) and 21 controls from our hospital (Table 2) . PCDAI or PUCAI was calculated as follows: CD active group (PCDAI ≥ 10, CD AC group), CD remission group (PCDAI < 10, CD RE group), UC active group (PUCAI ≥ 10 group); 19 in CD AC group, seven in CD RE group, and seven in UC group (Table 3) . Ileocecal tissues were collected by endoscopy from all patients. qRTPCR was used to evaluate miR15a and Cdc42 gene expression in these tissues, and the CD AC group, CD RE group, and UC group were compared with the age and sexmatched control group (Table 3) . qRTPCR showed that miR15a expression was increased in the CD AC group compared to the control group ( Figure 5A ), while it was decreased in the CD RE group compared to the CD AC group ( Figure 5A ). Cdc42 was decreased in the CD AC group compared to the control group ( Figure 5B), while it was increased in the CD RE group compared to the CD AC group ( Figure 5B ). Cdc42 expression was decreased in the UC group compared to control group ( Figure 5B ). miR15a expression did not significantly change between the UC and control groups ( Figure 5A relation between miR15a, Cdc42 and PCDAI. We found that miR15a was positively correlated with PCDAI ( Figure  5C ), Cdc42 was negatively correlated with PCDAI ( Figure  5D ), and miR15a was negatively correlated with Cdc42 ( Figure 5E ).
Altogether, these results demonstrate that miR15a negatively regulates Cdc42 in pediatric IBD patients, and both are correlated with PCDAI. PCDAI is one of the indicators of the severity of CD.
DISCUSSION
IBD is a multifactorial disease, characterized by chronic inflammation of the gastrointestinal tract. MicroRNAs can offer a potential missing link between the genetic, environmental and immunological factors involved in the pathogenesis of IBD [26, 27] . They play an important role in the development of IBD. MicroRNAs mediate post transcriptional gene expression by binding to the 3'UTRs of target genes, thus inhibiting protein translation or inducing gene degradation. Altered expression of micro RNAs has been linked to different cell functions, including signal transduction, differentiation, proliferation and apoptosis [2830] . In this study, we focused on miR15a and found that miR15a can bind the 3'UTR of Cdc42, suggesting that Cdc42 is a target gene of miR15a. Dualluciferase reporter assay confirmed that Cdc42 is a miR15a target gene. Our results were similar to other studies [2123] . Cdc42 is a Rho family small GTPase that is known to control various cellular functions including adhesion, migration, transcription and growth [10, 11] . It has a special role in intestinal stem cell division, survival and differentiation in mice [10, 14] . It was recently reported that Cdc42 is critical for intestinal epithelial stem cell differentiation into a functional intestinal barrier [10, 14] . A number of studies in IBD patients have shown that intes tinal barrier function is disrupted in active and quiescent disease states.
High TNFα expression has been found in most pedia tric patients [25] . TNFα has an important role in microRNA expression. Therefore, we used TNFα to stimulate Caco2 cells and found that TNFα upregulated miR15a and downregulated Cdc42. This result demonstrated that TNFα has an important role in miR15a expression and that miR15aCdc42 signaling participated in the development of IBD. Therefore, we used lentiviruses to up or downregulate miR15a expression in Caco2 cells. We found that in the miR15a mimic group, Cdc42 was downregulated, but upregulated in cells infected with a miR15a inhibitor. These results show that miR15a negatively regulates Cdc42.
We also found that after TNFα stimulation, Ecadherin and ZO1 expression decreased in Caco2 cells. These belong to the intestinal epithelial junction proteins. The change in epithelial junction proteins can disrupt the epithelial barrier. A number of studies in IBD patients has demonstrated that intestinal barrier function is disrupted. We also found that expression of Ecadherin and ZO1 also decreased in miR15a mimic Caco2 cells, similar to cells with high TNFα expression. However, Ecadherin and ZO1 expression did not decrease in the miR15a inhibitor + TNFα group compared to the WT group.
We transfected Caco2 cells with Cdc42 lentivirus (LvCdc42) or its negative control (LvCdc42NC), and then stimulated both with TNFα. We found that in Lv Cdc42 cells, Ecadherin and ZO1 expression increased compared to LvCdc42NC + TNFα or miR15a mimic cells, suggesting that Cdc42 overexpression can reverse epithelial junction expression caused by miR15a upre gulation. These results demonstrated that miR15a nega tively regulates intestinal epithelial junctions through Cdc42 in Caco2 cells. The miR15aCdc42 signaling pathway is involved in many other biological processes, and our study confirmed it to be important in the devel opment of gastrointestinal inflammation.
We investigated miR15a and Cdc42 expression in pediatric IBD patients and found that miR15a was increased and Cdc42 was decreased in the CD AC group compared to the control group. In contrast, miR 15a was decreased and Cdc42 increased in the CD RE group compared to the CD AC group. We analyzed the correlation between miR15a, Cdc42 and PCDAI and found that miR15a was positively correlated with PCDAI, Cdc42 negatively correlated with PCDAI, and miR15a negatively correlated with Cdc42. These results demonstrated that miR15a negatively regulates Cdc42 in children with IBD, and both are correlated with PCDAI.
This study had some limitations. First, we found a cor relation between miR15a, Cdc42 and PCDAI, but the R values were not high, possibly due to the small number of patients. Second, we only included seven UC patients, which may be one of the reasons why we did not find altered expression of miR15a in UC patients.
This study shows that miR15a negatively regulates intestinal epithelial junctions through Cdc42, but we did not study how Cdc42 regulates intestinal epithelial junc tions. This will be studied in our future research.
In conclusion, miR15a negatively regulates intestinal epithelial junctions through Cdc42 in Caco2 cells and pediatric IBD. This is believed to be the first study of the miR15aCdc42 signaling pathway in pediatric IBD patients. Additionally, this study provides evidence that Cdc42 is a miR15a target gene, and this will provide a critical clue for understanding IBD development.
ARTICLE HIGHLIGHTS
Research background
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder with an increasing prevalence. Pediatric IBD has severe phenotypes, but the etiology of IBD remains unknown. A number of studies have shown that microRNAs participate in the development of IBD and that miR-15a has an altered expression level in IBD patients, but the underlying mechanisms have not been fully elucidated. Cell division cycle (Cdc)42 is a Rho family small GTPase, and it has been reported that Cdc42 is critical for intestinal epithelial stem cell differentiation into a functional intestinal barrier. MicroRNA-Cdc42 signaling plays a role in some biological processes, and Target Scan identified a putative seed region of miR-15a in the wild-type 3'-UTR of Cdc42. Thus, we hypothesized that miR-15a regulates Cdc42 to disrupt the intestinal barrier in IBD development.
Research motivation
The main goal of this study is to find the role of microRNA-Cdc42 signaling in pediatric IBD development. Our study found that miR-15a negatively regulates intestinal epithelial junctions through Cdc42 in Caco-2 cells and in pediatric IBD. This finding will provide a critical clue for understanding IBD development in the future.
Research objectives
The objectives of this study were to determine whether Cdc42 is regulated by miR-15a in the development of pediatric IBD. Through our study, we found that miR-15a negatively regulates intestinal epithelial junctions through Cdc42 in Caco-2 cells and in pediatric IBD. This study provides a new clue for understanding the development of IBD and will help researchers study the etiology of IBD and provide new methods for IBD treatment in the future.
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Research methods
We cultured cells, used tumor necrosis factor (TNF)-α to stimulate cells, employed plasmids and lentiviruses to change miR-15a and Cdc42 expression, performed dual-luciferase assay, quantitative reverse transcription polymerase chain reaction and immunofluorescence. Statistical analysis was performed using t test of variance and Pearson's r test of correlation using Graphpad Prism version 6.0.
Research results
We demonstrated that miR-15a negatively regulates intestinal epithelial junctions through Cdc42 in Caco-2 cells and pediatric IBD. This is believed to be the first study of the miR-15a-Cdc42 signaling pathway in pediatric IBD patients.
This study had some limitations. First, we found a correlation between miR-15a, Cdc42 and Pediatric Crohn's Disease Activity Index, but the R values were not high, possibly due to the small number of patients. Second, we only included seven ulcerative colitis (UC) patients, which may be one of the reasons why we did not find altered miR-15a expression in UC patients. Last, we showed that miR-15a negatively regulates intestinal epithelial junctions through Cdc42, but we did not study how Cdc42 regulates intestinal epithelial junctions. This will be studied in our future research.
Research conclusions
MiR-15a negatively regulates intestinal epithelial junctions through Cdc42 in pediatric IBD. This is believed to be the first study of the miR-15a -Cdc42 signaling pathway in pediatric IBD patients. Additionally, this study provides evidence that Cdc42 is a miR-15a target gene, and this will provide a critical clue for understanding IBD development, and may also provide new methods for future IBD treatments.
Research perspectives
It is better get more patients, particularly UC patients. We will study how Cdc42 regulates intestinal epithelial junctions in our future research.
